在B细胞慢性淋巴增殖性疾病中的SLAM家族受体
Dominik Kľoc1, Slavomír Kurhajec2, Mykhailo Huniadi1
1Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 04011 Košice, Slovakia.
International journal of molecular sciences
|April 13, 2024
概括
信号淋巴细胞激活分子 (SLAM) 家庭受体在各种免疫细胞上表达,并在B细胞慢性淋巴增殖性疾病 (B-CLPD) 中发现. 这些SLAMF受体可以作为B-CLPD的诊断标记物和治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 信号淋巴细胞激活分子 (SLAM) 受体家族 (SLAMF) 包含CD2超级家族中的9种糖蛋白.
- SLAMF受体在调节免疫细胞分化和激活方面发挥着至关重要的作用.
- 这些受体在广泛的造血细胞中表达,包括淋巴细胞,髓状细胞和血小板.
研究的目的:
- 审查关于B细胞慢性淋巴增殖性疾病 (B-CLPD) 中SLAMF受体和适应蛋白 (SAP,EAT-2) 表达的当前知识.
- 探索SLAMF受体作为B-CLPD的诊断和预后标记物的潜力.
- 确定SLAMF受体作为B-CLPD治疗的潜在治疗点.
主要方法:
- 审查关于SLAMF受体表达的现有文献.
- 在正常B细胞成熟过程中对SLAMF受体表达的分析.
- 在B-CLPD细胞系和患者样本中检测SLAMF受体.
主要成果:
- 在正常的B细胞成熟过程中,SLAMF受体得到表达.
- 几种SLAMF受体存在于B-淋巴瘤癌细胞系和B-CLPD患者的病态B细胞中.
- 在B-CLPD中还研究了适应蛋白SAP和EAT-2的表达.
结论:
- SLAMF受体与B-CLPD病原发生有关.
- SLAMF受体显示出作为B-CLPD的诊断/差异诊断标记物的潜力.
- 在B-CLPD中,SLAMF受体代表了新药开发的有希望的标.
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Cells of the Adaptive Immune Response
983
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
983
Diversity of Antigen Receptors
581
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
581
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


